Premium
The latanoprost monotherapy survey in New Zealand, 2000
Author(s) -
Elder Mark,
Mora Justin
Publication year - 2001
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1046/j.1442-9071.2001.d01-23.x
Subject(s) - latanoprost , medicine , optometry , ophthalmology , glaucoma
ABSTRACT Background : A State subsidy for latanoprost has been recently introduced. It is subject to several conditions including that it should only be used as monotherapy. Method : A prospective survey of all New Zealand ophthalmologists was undertaken to determine the outcome of the widespread trial of latanoprost monotherapy. The return rate was 82%. Results : Of 2900 patients on latanoprost nation‐wide, 14.7% were monotherapy failures. Of these, 93% were due to inadequate intraocular pressure control but this subgroup had adequate control on two or more medications in 88%. Ophthalmologists had 635 patients that were not trialed as monotherapy, of which 565 (89%) were due to a perceived risk. Conclusions : In those patients treated with latanoprost, 85% were adequately controlled as monotherapy.